Published in J Hypertens on December 01, 1998
Family Blood Pressure Program - GenNet Network | NCT00005268
Social technology restriction alters state-anxiety but not autonomic activity in humans. Am J Physiol Regul Integr Comp Physiol (2011) 0.89
Attenuation of sympathetic baroreflex sensitivity during the onset of acute mental stress in humans. Am J Physiol Heart Circ Physiol (2011) 0.83
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
The dawn of Darwinian medicine. Q Rev Biol (1991) 2.35
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry (1994) 1.53
Marital quality and psychological adjustment to widowhood among older adults: a longitudinal analysis. J Gerontol B Psychol Sci Soc Sci (2000) 1.51
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety (1997) 1.27
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry (2001) 1.11
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med (1980) 1.08
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02
Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry (1984) 1.01
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01
Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00
Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension (1996) 1.00
Evolution and the origins of disease. Sci Am (1998) 1.00
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med (1996) 0.96
Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92
Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens (2001) 0.91
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91
Ages of onset of DSM-III anxiety disorders. Compr Psychiatry (1985) 0.91
Effect of alcohol on social phobic anxiety. Am J Psychiatry (1999) 0.90
Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med (1990) 0.90
Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension (1994) 0.90
Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens (1994) 0.90
Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med (1990) 0.89
Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens Suppl (1984) 0.89
Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press (2001) 0.89
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study. J Hum Hypertens (2004) 0.89
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press (2001) 0.88
University of California, Davis, conference: Mild hypertension. Am J Med (1988) 0.87
Experimental model of severe renal hypertension. J Lab Clin Med (1976) 0.87
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther (1985) 0.87
Determinants of baroreflex sensitivity in man. J Lab Clin Med (1978) 0.87
Usefulness of home BP determination in treating borderline hypertension. JAMA (1982) 0.86
Cholecystokinin-4 and panic. Arch Gen Psychiatry (1990) 0.86
Abnormalities of plasma volume in borderline hypertension. Arch Intern Med (1971) 0.86
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension (1983) 0.85
Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents. Hypertension (1984) 0.85
Effect of circulating epinephrine on platelet function and hematocrit. Hypertension (1995) 0.85
Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens (1997) 0.85
Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol (Oxf) (1981) 0.85
Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol (1975) 0.85
The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens (1999) 0.85
Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry (1994) 0.85
Relevance of heart rate as a risk factor in hypertension. Curr Hypertens Rep (1999) 0.85
Syndrome X: is it for real? Genet Epidemiol (1998) 0.85
Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet (1976) 0.84
Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens (1994) 0.84
Alcohol abuse among clinically anxious patients. Behav Res Ther (1986) 0.84
Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review. J Cardiovasc Pharmacol (1985) 0.84
Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med (1985) 0.83
The role of the autonomic nervous system in hypertension. Hypertens Res (1995) 0.83
A comparison of panic disorder and agoraphobia with panic attacks. Compr Psychiatry (1985) 0.83
Anger and anxiety in borderline hypertension. Psychosom Med (1986) 0.83
Heritability of left atrial size in the Tecumseh population. Eur J Clin Invest (2002) 0.83
3D.01: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF STROKE OR CARDIAC EVENTS IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL. J Hypertens (2015) 0.83
Plasma norepinephrine variations with dietary sodium intake. Hypertension (1980) 0.83